The Allergan implants formally comprised the broadest product range.
As of December 2018 we do not use any of the macro-textured Allergan breast implants as the macro texturing has a higher linkage to the uncommon BIA-ALCL.
Allergan therefore withdrew their entire range of implants from the market. The smooth shelled implant was unaffected as the safety consideration related to the textured surface of their other implants. The whole textured range is therefore withdrawn in Europe. The heavy macro texturing of an implant is no longer generally advisable when there is an alternative and in the current climate of BIA-ALCL, we recommend you consider these alternatives including smooth shell implants or microtextured where the risks of this uncommon malignancy is lower.